| Literature DB >> 25237640 |
Allan Demetrius Leite de Oliveira1, Fabiola Fernandes Galvao Rodrigue2, Henrique Douglas Melo Coutinho3, Jose Galberto Martins da Costa2, Irwin Rose Alencar de Menezes4.
Abstract
BACKGROUND: Several studies have shown that species of the genus Hyptis, have promising antimicrobial and antifungal effects.Entities:
Keywords: Aminoglycoside; Antimicrobial Resistance; Essential Oils; Hyptis martiusii
Year: 2014 PMID: 25237640 PMCID: PMC4165191 DOI: 10.17795/jjnpp-13521
Source DB: PubMed Journal: Jundishapur J Nat Pharm Prod ISSN: 1735-7780
Chemical Compostion of Essential Oil From Hyptis martiusii Benth
| Constituents | Retention Time, min | Compositions, % | KI |
|---|---|---|---|
|
| 9.6 | 6.8 | 1002 |
|
| 10.6 | 7.0 | 1031 |
|
| 30.9 | 9.2 | 1409 |
|
| 31.8 | 2.7 | 1441 |
|
| 32.7 | 2.2 | 1455 |
|
| 34.0 | 3.8 | 1482 |
|
| 34.5 | 5.4 | 1485 |
|
| 34.8 | 1.5 | 1496 |
|
| 42,8 | 2.6 | 1645 |
|
| 43.4 | 3.7 | 1654 |
|
| 35.8 | 10.6 | 1500 |
|
| 36.0 | 2.4 | 1503 |
|
| 36.8 | 3.1 | 1523 |
|
| 37.0 | 2.3 | 1564 |
|
| 39.0 | 7.4 | 1583 |
|
| 39.2 | 2.1 | 1585 |
|
| 39.6 | 2.4 | 1596 |
|
| 39.8 | 3.3 | 1601 |
|
| 41.5 | 1.3 | 1624 |
|
| 12.9 | 1.6 | 1089 |
|
| 16.3 | 2.6 | 1146 |
|
| 84.0 |
a Abbreviation: KI, Kovats retention index
Figure 1.Chromatogram of the Essential oil of H. martiusii
Clinical Isolates Bacterial Antibiotic Resistance [a]
| Bacteria | Source | Antibiotic Resistance |
|---|---|---|
|
| surgical wound | Ast, Ax, Amp, Ami, Amox, Ca, Cfc, Cf, Caz, Cip, Clo, Im, Can, Szt, Tet, Tob |
|
| surgical wound | Oxa, Gen, Tob, Ami, Can, Neo, Para, But, Sis, Net |
a Abbreviation: Ast, aztreonam; Ax, amoxicillin; Amp, ampicillin; Ami, amikacin; Amox, amoxicillin; Ca, cefadroxil; Cfc, cefaclor; Cf, cefalotin; Caz, ceftazidime; Cip, ciprofloxacin; Chlo, chloramphenicol; Im, imipenem; Kan, kanamycin; Szt, sulfametim; Tet, tetracyclin; Tob, tobramycin; Oxa, oxacillin; Gen, gentamicin; Neo, neomycin; Para,paramomycin; But, butirosin; Sis, sisomicin; Net, netilmicin.
Minimal Inhibitory Concentration Values (μg/mL) of Aminoglycosides and EOHm
| Bacterial | ||||||
|---|---|---|---|---|---|---|
|
| 64 | 512 | ≥ 1024 | 512 | 256 | 512 |
|
| 64 | 256 | 256 | 256 | 128 | 128 |
|
| 32 | 256 | 128 | 128 | 256 | 64 |
|
| 16 | 64 | 64 | 64 | 256 | 64 |
|
| 16 | 256 | 128 | 64 | 256 | 128 |
Minimal Inhibitory Concentration Values (μg/mL) Combination of Aminoglycosides (MIC/8) in the Absence and Presence of 8 μg/mL of EOHm [a]
| Bacteria | AMI | GENT | NEO | KAN | ||||
|---|---|---|---|---|---|---|---|---|
| OE | CONT | OE | CONT | OE | CONT | OE | CONT | |
|
| 32 | 32 | 64 | 64 | 64 | 16 | 64 | 64 |
|
| 32 | 32 | 64 | 64 | 16 | 16 | 32 | 32 |
|
| 128 | 128 | 64 | 64 | 128 | 16 | 128 | 128 |
|
| 256 | 4 | 128 | 64 | 512 | 16 | 128 | 16 |
|
| 64 | 16 | 512 | 512 | 32 | 32 | 128 | 128 |
|
| 32 | 32 | 64 | 64 | 16 | 16 | 64 | 64 |
a Abbreviations: AMI, amikacin; GENT, gentamycin; NEO, neomycin; KAN, kanamycin; OE, essencial oil; CONT, negative control (aminoglycoside only).
Modification of the Antibiotic Activity of the Volatile Compounds of H. martiusii Essential oil by Gaseous Contact [a, b, c]
| Antibiotic | N. TRA | DMSO | EOHm, 50% | EOHm, 25% | EOHm, 12% | EOHm, 6% |
|---|---|---|---|---|---|---|
|
| ||||||
| Control GENT | 16.3 ± 0.6 | 16.7 ± 0.6 | 60.0 ± 0.5 | 60.1 ± 0.6 | 16.3 ± 0.8 | 16.3 ± 0.5 |
| Increase, % | - | - | 268.1 | 268.7 | - | - |
| Control AMI | 17.3 ± 0.6 | 17.3 ± 0.6 | 74.2 ± 0.0 | 47.0 ± 0.5 | 17.3 ± 0.7 | 17.3 ± 0.0 |
| Increase, % | - | - | 328.9 | 171.7 | - | - |
| Control TOBRA | 15 ± 0.7 | 15.3 ± 0.7 | 57 ± 0.3 | 34±0.0 | 25 ± 0.3 | 18 ± 0.0 |
| Increase, % | - | - | 280 | 126.7 | 66.7 | 20 |
|
| ||||||
| Control GENT | 14.3 ± 0.6 | 14 ± 0.0 | 17 ± 0.7 | 14.3 ± 0.4 | 14.3 ± 0.8 | 14.3±0.0 |
| Increase, % | - | - | 18.9 | - | - | - |
| Control AMI | 15 ± 0.0 | 15.3 ± 0.6 | 24 ± 0.3 | 15 ± 0.4 | 15.2 ± 0.7 | 15 ± 0.5 |
| Increase, % | - | - | 60 | - | 1.3 | - |
| Control TOBRA | 16 ± 0.0 | 16 ± 0.3 | 18 ± 0.0 | 17 ± 0.7 | 17 ± 0.7 | 17 ± 0.7 |
| Increase, % | - | - | 12.5 | 6.3 | 6.3 | 6.3 |
|
| ||||||
| Control GENT | 15 ± 0.0 | 15 ± 0.0 | 21 ± 0.0 | 17 ± 0.0 | 15±0.0 | 15±0.0 |
| Increase, % | - | - | 40 | 13.3 | - | - |
| Control AMI | 17 ± 0.7 | 16.5 ± 0.3 | 31 ± 0.0 | 22 ± 0.0 | 17 ± 0.0 | 17 ± 0.0 |
| Increase, % | - | - | 82.4 | 29.4 | - | - |
| Control TOBRA | 15±0.7 | 15 ± 0.0 | 27 ± 0.0 | 19±0.0 | 15 ± 0.0 | 15 ± 0.0 |
| Increase, % | - | - | 80 | 26.7 | - | - |
|
| ||||||
| Control GENT | 18 ± 0.3 | 18.3 ± 0.0 | 23 ± 0.0 | 18 ± 0.0 | 18 ± 0.0 | 18 ± 0.0 |
| Increase, % | - | - | 27.8 | - | - | - |
| Control AMI | 18 ± 0.0 | 18 ± 0.0 | 32 ± 0.0 | 23 ± 0.0 | 18 ± 0.0 | 18 ± 0.0 |
| Increase, % | - | - | 77.8 | 27.8 | - | - |
| Control TOBRA | 14 ± 0.0 | 14.5 ± 0.7 | 24 ± 0.0 | 19 ± 0.3 | 18 ± 0.0 | 18 ± 0.0 |
| Increase, % | - | - | 71.4 | 35.7 | 28.6 | 28.6 |
|
| ||||||
| Control GENT | 22.0 ± 0.5 | 22.0 ± 0.5 | 26 ± 0.3 | 24 ± 0.0 | 22.0 ± 0.5 | 22.0 ± 0.5 |
| Increase, % | - | - | 18.2 | 9.1 | - | - |
| Control AMI | 25.0 ± 0.5 | 25.0 ± 0.5 | 35 ± 0.5 | 27 ± 0.4 | 25.0 ± 0.5 | 25.0 ± 0.5 |
| Increase, % | - | - | 40 | 8 | - | - |
| Control TOBRA | 25.5 ± 0.6 | 25.5 ± 0.6 | 34 ± 0.3 | 30 ± 0.0 | 25.5 ± 0.6 | 25.5 ± 0.6 |
| Increase, % | - | - | 33.3 | 17.6 | - | - |
|
| ||||||
| Control GENT | 17.0 ± 0.0 | 17.0 ± 0.0 | 20 ± 0.2 | 19.2 ± 0.2 | 17.0 ± 0.0 | 17.0 ± 0.0 |
| Increase, % | - | - | 17.6 | 12.9 | - | - |
| Control AMI | 20.5 ± 0.5 | 20.5 ± 0.5 | 21 ± 0.0 | 21 ± 0.0 | 20.5 ± 0.5 | 20.5 ± 0.5 |
| Increase, % | - | - | 2.4 | 2.4 | - | - |
| Control TOBRA | 17.0 ± 0.0 | 17.0 ± 0.0 | 30.0 ± 0.4 | 28 ± 0.2 | 17.0 ± 0.0 | 17.0 ±0.0 |
| Increase, % | - | - | 76.5 | 64.7 | - | - |
a Abbreviations: AMI, amikacin; DMSO, dimethyl sulfoxide; GENT, gentamicin; N. TRA, no treated; EOHm, essential oil of H. martiusii; TOBRA, tobramycin.
b Averages following by same letters, in the column, don't differ significantly amongst themselves (a) (n = 3, P < 0.05, test of Tukey). Averages following by different letters, in the line, differ significantly when compared with the respective control, for each microorganism (the n = 3, P < 0,001 ANOVA) and (b) (the n = 3, P < 0.01 ANOVA)
c The results are expressed as Mean + SEM.